Date posted: December 12, 2024, 2:43 pm
In this episode, we discuss the efficacy and safety of semaglutide and tirzepatide for weight loss with a particular focus on the legal, regulatory, and safety aspects of these “compounded” GLP-1 receptor agonist medications.
Date posted: October 4, 2024, 10:34 am
In this episode, we review the recommendations from the 2024 SCCM/ASHP stress ulcer prophylaxis guidelines and highlight three of the more recent landmark critical care trials investigating the role of stress ulcer prophylaxis.
Date posted: August 9, 2024, 4:00 pm
In this episode, we discuss the approach to deprescribing for several drugs such as benzodiazepine receptor agonists, cholinesterase inhibitors, memantine, antipsychotics, and antihyperglycemics.
Date posted: June 28, 2024, 6:00 am
In this episode, we review the pharmacology, pharmacokinetics, adverse effects, monitoring, medicinal chemistry, and more of loop diuretics.
Date posted: May 7, 2024, 6:00 am
In this episode, we discuss principles for medication use in the geriatric patient population and summarize the updated 2023 ľ¹ÏÖ±²¥ Geriatrics Society Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.
Date posted: April 16, 2024, 6:00 am
In this episode, we discuss artificial intelligence large language models (LLMs) and how these will impact the future of the practice of pharmacy.
Date posted: March 26, 2024, 6:00 am
In this episode, we review the pharmacology, indications, adverse effects, monitoring, and unique drug characteristics of HMG CoA reductase inhibitors (“statins”).
Date posted: March 5, 2024, 6:00 am
In this recurring episode, we discuss the important updates from the 2024 ľ¹ÏÖ±²¥ Diabetes Association Guidelines!
Date posted: February 13, 2024, 6:00 am
In this episode, we speak with Janeen Winnike, the Associate Dean for Student Affairs at Rosalind Franklin and a co-course director for the Pharmacy Law course at the university. We review some of the key points regarding federal and Illinois pharmacy law – a must-listen especially for graduates preparing for their MPJE exam after graduation!
Date posted: January 23, 2024, 6:00 am
In this episode, we review evidence-based guidelines for the emergency reversal of warfarin, dabigatran, and the oral Xa inhibitors (apixaban, edoxaban, and rivaroxaban).